| Literature DB >> 35954789 |
Julia Pfisterer1, Constantin Rausch1, Doreen Wohlfarth1, Philip Bachert1, Darko Jekauc1, Kathrin Wunsch1.
Abstract
Overweight and obesity, including their prevalence and consequences, reflect a leading public health problem. Studies have already shown that physical activity leads to a reduction in body weight in children and adults. However, the university setting has rarely been investigated. The aim of this review is, therefore, to examine and summarize the effectiveness of physical-activity-based interventions to reduce obesity and overweight in university students. Three databases (PubMed, Scopus, and Web of Science) were searched for relevant studies published in English between January 2010 and February 2022. Quantitative studies conducting a physical-activity-based intervention with overweight or obese university students and reporting changes in BMI were included. Data were described in a narrative synthesis. Out of 16 included studies, 11 reported a significant reduction in BMI. However, all studies except one were able to demonstrate some BMI improvements, whereas all studies reported significant changes in at least one health-related indicator. Aerobic exercises were able to demonstrate the greatest reductions in BMI. This review is the first systematic presentation on the effectiveness of physical-activity-based interventions in overweight and obese university students. Future work should reconsider BMI as the primary outcome if appropriate within the respective study design (i.e., to measure long-term effects). More interventions are needed to improve strategies.Entities:
Keywords: BMI; change; obesity; overweight; physical-activity-based interventions; review; tertiary education; university students
Mesh:
Year: 2022 PMID: 35954789 PMCID: PMC9368556 DOI: 10.3390/ijerph19159427
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow chart of study selection process.
Study characteristics of the included studies.
| Source | Design and Theoretical Framework | Population * | Intervention | Duration and Frequency | Intensity |
|---|---|---|---|---|---|
| Chen et al. (2021) [ | Randomized Controlled Trial | IG: cycling combined with blood flow restriction training (BFRT) by wearing air pressure belts | 12 weeks (2× per week, 3 sessions/time with 15 min/session) | IG: low-intensity cycling (40% VO2max) with BFRT exercises; 1 min rest between sessions | |
| Dalibalta et al. (2017) [ | Controlled Clinical Trial | IG (BMI ≥ 25): exercise program (not further defined) | 8 weeks (3× per week with 60 min/session) | Moderate-high intensity (not further defined) | |
| DiFrancisco-Donoghue et al. (2018) [ | Controlled Clinical Trial | Fitbit-Plus group: wrist activity trackers, participation in weekly mentored walks/runs, weekly emails (Sunday) offering fitness challenges and feedback on step count | 39 weeks | Not mentioned | |
| Gifari et al. (2021) [ | Controlled Clinical Trial | PWI: pre-meal water consumption (PWI); 600 mL before each mealtime with a total water intake of 1.8 L/day | 8 weeks (3× per week with 18 min/session) | 70–85% of HR-max | |
| Ha and So (2012) [ | Controlled Clinical Trial | IG: combination of aerobic exercise (treadmill running) and resistance exercise (whole body) | 12 weeks (3× per week with 80 min/session) | Treadmill running: 60–80% of HRR | |
| Joseph et al. (2014) [ | Cohort Study | aerobic exercise | 12 weeks (4× per week with 30–60 min/session) | Moderate | |
| Joseph et al. (2016) [ | Cohort Study | An Internet-enhanced physical activity program consisting of 1) aerobic exercise and 2) an Internet-based application as a promotion tool | 12 weeks (4× per week with 30–60 min/session) | Moderate | |
| Lee et al. (2021) [ | Cohort Study | High-intensity circuit training | 4 weeks (3× per week with 40 min/session) | Week 1–2: 60–70% HRR (RPE Scale = 13–14) | |
| Mathunjwa et al. (2013) [ | Cohort Study | Tae Bo | 10 weeks (3× per week with 60 min/session) | Week 1–5: moderate (Borg RPE Scale = 11–13, 135 bpm) | |
| Moravveji et al. (2019) [ | Randomized Controlled Trial | 1200 m run (each week increase by 400 m) | 8 weeks (3× per week) | 60–75% of maximum HR | |
| Pacholek et al. (2021) [ | Controlled Clinical Trial | COM: combination program (aerobic and resistance) | 4 weeks (4× per week with 50 min/session) | Subjective feelings with maximal effort (not further defined) | |
| Roopchand-Martin et al. (2015) [ | Cohort Study | Dance intervention utilizing the XBOX Kinect 360 and Just Dance 4 | 6 weeks | Moderate (Borg RPE Scale = 12–14) | |
| Siqiang (2018) [ | Controlled Clinical Trial | IG: aerobic exercise divided into two (i.e., rope skipping, swimming) | 12 weeks (4× per week with 60 min/session, divided into two: half an hour in the morning, half an hour in the afternoon) | Moderate (120–150 bpm) | |
| Sun et al. (2020) [ | Randomized Controlled Trial | IG: high-intensity interval training (not further defined) | 12 weeks (5× per week) | IG: 4 min with 85% VO2max/HR = 174 bpm, then 2 min with 50% VO2max, followed by 5 min relaxation (repeated 5×) | |
| Zhang, W. and Yu, L. (2021) [ | Controlled Clinical Trial | IG: combination of aerobic exercises and resistance training | 16 weeks (3× per week with 60 min/session) | Aerobic exercises: 30–80% of max HR, according to stage of the training | |
| Winters-Stone et al. (2020) [ | Randomized Controlled Trial | IG: whole-body vibration (WBV) training | 24 weeks (3× per week with 20 min/session) | Week 1–3: 30 Hz |
Sample size contains the number of subjects included in the final analysis. IG = intervention group. CG = control group. HR = heart rate. HRR = heart rate reserve. RM = repetition maximum. RPE = rating of perceived exertion. VO2max = maximum oxygen uptake. bpm = beats per minute. * Population characteristics are divided into the number of female and number of overweight people (number of female/number of overweight). ** The results of this group are not considered in Table A2, because of the inclusion of a nutrition intervention. *** Since no drop-outs were reported, the exact number of participants can only be assumed.
Assessment of study quality using the Quality Assessment Tool for Quantitative Studies (EPHPP).
| Study | Selection | Study | Con- | Blinding | Data | Withdrawals and | Global |
|---|---|---|---|---|---|---|---|
| Chen et al. (2021) [ | 2 | 1 | 1 | 3 | 1 | 1 | 2 |
| Dalibalta et al. (2017) [ | 2 | 1 | 3 | 2 | 1 | 3 | 3 |
| DiFrancisco-Donoghueet al. (2018) [ | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Gifari et al. (2021) [ | 1 | 1 | 3 | 2 | 1 | 1 | 2 |
| Ha and So (2012) [ | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Joseph et al. (2014) [ | 2 | 2 | 3 | 2 | 1 | 1 | 2 |
| Joseph et al. (2016) [ | 2 | 2 | 3 | 2 | 1 | 1 | 2 |
| Lee et al. (2021) [ | 2 | 2 | 3 | 3 | 1 | 3 | 3 |
| Mathunjwa et al. (2013) [ | 2 | 2 | 3 | 2 | 1 | 1 | 2 |
| Moravveji et al. (2019) [ | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Pacholek et al. (2021) [ | 2 | 1 | 3 | 2 | 1 | 3 | 3 |
| Roopchand-Martin | 3 | 2 | 3 | 2 | 1 | 1 | 3 |
| Siqiang (2018) [ | 2 | 1 | 1 | 2 | 1 | 3 | 2 |
| Sun et al. (2020) [ | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Zhang, W. and Yu, L. (2021) [ | 2 | 1 | 1 | 2 | 1 | 3 | 2 |
| Winters-Stone et al. (2020) [ | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
Ratings: 1= strong, 2 = moderate, 3 = weak.
Individual results of the included studies (change of BMI).
| Study | Control Group | Intervention Group(s) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Intervention | Difference Pre–Post (SD) | Difference Pre–Post (%) | ES/Significance | Baseline | Post-Intervention | Difference | Difference Pre–Post | ES/Significance | |
| Mean BMI | Mean BMI | Mean BMI | Mean BMI | |||||||
| Chen et al. (2021) [ | 30.30 (1.08) | 29.90 (1.44) | −0.40 | −1.32 | dav = 0.317 | 30.10 (0.95) | 29.0 (1.79) | −1.10 | −3.65 | dav = 0.803 * |
| Dalibalta et al. (2017) [ | 21.60 (2.05) | 21.10 (2.00) | −0.50 | −2.31 | dav = 0.247 * | 28.70 (3.27) | 28.10 (2.79) | −0.60 | −2.09 | dav = 0.198 * |
| DiFrancisco-Donoghue et al. (2018) [ | Men: −0.30 (0.50) | Fitbit-Plus men: 0.20 (1.70) | ||||||||
| Gifari et al. (2021) [ | PWI: 26.6 (3.6) | PWI: 26.7 (3.6) | PWI: 0.1 | PWI: 0.38 | PWI: dav = 0.028 | |||||
| Ha and So (2012) [ | 24.18 (1.63) | 24.38 (1.66) | 0.20 | 0.83 | 24.97 (2.73) | 24.76 (3.01) | −0.21 | −0.84 | dppc2 = 0.179 | |
| Joseph et al. (2014) [ | 33.27 (6.53) | 32.57 (6.62) | −0.70 | −2.10 | dav = 0.106 * | |||||
| Joseph et al. (2016) [ | 33.80 (5.70) | 32.90 (6.00) | −0.90 | −2.66 | dav = 0.154 | |||||
| Lee et al. (2021) [ | 25.14 (2.51) | 24.24 (2.60) | −0.9 (0.35) | −3.58 | dav = 0.352 * | |||||
| Mathunjwa et al. (2013) [ | 32.26 (5.65) | 30.11 (5.46) | −2.15 | −6.66 | d = 0.2 * (1) | |||||
| Moravveji et al. (2019) [ | 27.57 (1.62) | 28.04 (1.46) | 0.47 | 1.70 | Continuous group: 26.77 (1.53) | Continuous group: 26.08 (1.21) | Continuous group: −0.69 | Continuous group: −2.58 | Continous group: dppc2 = 0.704 * (2) | |
| Pacholek et al. (2021) [ | COM: 31.30 (8.61) | COM: 31.30 (8.36) | COM: 0 | COM: 0 | COM: dav = 0 | |||||
| Roopchand-Martin et al. (2015) [ | 30.51 (5.18) | 30.31 (5.39) | −0.2 | −0.66 | dav = 0.038 | |||||
| Siqiang (2018) [ | 26.80 (3.40) | 24.10 (2.90) | −2.70 | −10.07 | dav = 0.857 * | 25.50 (2.70) | 21.60 (3.10) | −3.90 | −15.29 | dav = 1.345 * |
| Sun et al. (2020) [ | 30.54 (3.86) | 28.45 (2.76) | −2.09 | −6.84 | dav = 0.631 * | 30.85 (3.79) | 28.17 (2.89) | −2.68 | −8.69 | dav = 0.802 * |
| Zhang, W. and Yu, L. (2021) [ | 22.54 (0.71) | 22.68 (1.11) | 0.14 | 0.62 | 22.06 (0.98) | 21.64 (0.85) | −0.42 | −1.90 | dppc2 = 0.641 * | |
| Winters-Stone et al. (2020) [ | 28.27 (26.48; 30.07) | Not available (4) | 0.64 (0.31; 0.96) | 2.26 | Total: 28.24 (23.87; 32.60) | Not available (4) | Total: 0.22 (−0.59; 1.03) | Total: 0.78 | Total: | |
Determined level of significance p = 0.05 (* p < 0.05). SD = standard deviation. ES = effect size (dav sensu Cumming, 2012; dppc2 sensu Morris, 2008). (1) Mathunjwa et al. (2013) reported effect sizes on their own. (2) Inconsistently reported significance in Table 1 and text. (3) Nutrition group is excluded. (4) Winters-Stone et al. (2020) reported only a 6-month change. (5) Participants with high adherence (≥80% of prescribed sessions).